ADSL: A Potential Drug Target and Biomarker for diseases (G158)

Target Name: ADSL

NCBI ID: G158

ADSL

ADSL: A Potential Drug Target and Biomarker for diseases

Introduction

ADSL (Adenylosuccinate Lyase, transcript variant X4) is a protein that plays a crucial role in the metabolism of adenosine, a well-known molecule that plays a vital role in various physiological processes in the body. Adenosine is produced by the body's own immune system and acts as an antioxidant, protecting cells from damage caused by free radicals. However, in some diseases, too much adenosine can become a problem, leading to inflammation and other negative effects. The craze has passed, and now ADSL has become a Promising areas of drug target (or biomarker) research. This article will describe the function and mechanism of ADSL as well as its potential and challenges as a drug target.

Function

ADSL is a ribosome-cleaved protein that belongs to a conserved family of single-chain glycoproteins. It catalyzes adenosine synthase activity in cells and is responsible for converting adenosine precursors into the active form of adenosine. The active site of ADSL is located in its core region, which contains two conserved cysteine 鈥嬧?媟esidues that serve as hydrogen bond acceptors to bind prosthetic groups.

The main function of ADSL is to regulate the intracellular adenosine content. ADSL activity is critical during inflammation and tissue repair. Activation of ADSL leads to an increase in intracellular adenosine content, thereby suppressing the immune system's response and reducing inflammation. At the same time, the inhibition of ADSL can enhance the immune system's resistance to disease and promote tissue repair.

Mechanism

The mechanism of action of ADSL mainly involves two aspects: inhibiting immune cell activity and promoting tissue repair.

1. Inhibit immune cell activity

Immune cells play an important role in disease development. However, when the activity of immune cells is overactivated, it can lead to an inflammatory response that can cause damage to tissues. Activation of ADSL inhibits immune cell activity, thereby reducing inflammation.

2. Promote tissue repair

ADSL activity is equally important during tissue repair. Inhibition of ADSL can reduce the increase in intracellular adenosine content, thereby reducing inflammation. At the same time, the activation of ADSL can also promote the release of growth factors from tissue cells and promote tissue repair.

potential and challenges

As a promising drug target, ADSL has the following potential and challenges:

1. Drug targets

ADSL has great potential as a drug target. Activation of ADSL leads to an increase in intracellular adenosine content, thereby suppressing the immune system's response and reducing inflammation. At the same time, the inhibition of ADSL can enhance the immune system's resistance to disease and promote tissue repair. This means that ADSL may become a potential drug for the treatment of various inflammatory diseases.

2. Biomarkers

ADSL activity can serve as a potential biomarker. Since the activity of ADSL is greatly affected by the intracellular environment, such as pH value, temperature, etc., the activity of ADSL can be used to detect changes in the intracellular environment, thereby serving as an important indicator for disease diagnosis or prognosis.

3. Drug development

ADSL has attracted considerable interest from scientists as a promising drug target. Currently, some companies are already committed to developing ADSL-related drugs. These medications may include anti-inflammatory drugs, immunomodulators, and antioxidants, among others. With further research, ADSL may become a drug with broad application prospects.

in conclusion

ADSL is a protein that regulates adenosine levels within cells. Its activation can suppress the immune system's response and reduce inflammation; at the same time, the inhibition of ADSL can enhance the immune system's resistance to disease and promote tissue repair. Since the activity of ADSL is greatly affected by the intracellular environment, the activity of ADSL can be used as a potential biomarker. Currently, ADSL has become a promising area of 鈥嬧?媎rug target (or biomarker) research. With further research, ADSL may become a drug with broad application prospects.

Protein Name: Adenylosuccinate Lyase

Functions: Catalyzes two non-sequential steps in de novo AMP synthesis: converts (S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate (SAICAR) to fumarate plus 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide, and thereby also contributes to de novo IMP synthesis, and converts succinyladenosine monophosphate (SAMP) to AMP and fumarate

The "ADSL Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ADSL comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets